Literature DB >> 34981470

The Effect of Herbal Medicine and Natural Bioactive Compounds on Plasma Adiponectin: A Clinical Review.

Mohammad Amin Atazadegan1, Mohammad Bagherniya2, Omid Fakheran3, Thozhukat Sathyapalan4, Amirhossein Sahebkar5,6,7,8.   

Abstract

Noncommunicable diseases (NCDs) are one of the major public health concerns globally. Most of the NCDs including insulin resistance, metabolic syndrome, type 2 diabetes mellitus, fatty liver disease, and coronary heart disease are related to obesity and are called obesity-related NCDs (OR-NCDs). However, adipocytes can reduce OR-NCDs by secreting adiponectin. Adiponectin has an inverse relationship with body fat. Obese people have impairment in differentiating pre-adipocytes to adipocytes, the process facilitated by adiponectin. Adiponectin directly increases insulin sensitivity and reduces obesity-related insulin resistance by down-regulating hepatic glucose production and increasing fatty acid (FA) oxidation in skeletal muscle. Considering the various beneficial effects of adiponectin on health, increasing adiponectin might be a promising approach to prevent and treat OR-NCDs. Recent studies have shown that nutraceuticals and medicinal compounds isolated from plants could prevent and treat various diseases, particularly cardiovascular diseases (CVDs), diabetes mellitus, obesity, and non-alcoholic fatty liver disease. However, to our knowledge, the effect of these natural products, including herbal supplements and functional foods on adiponectin, has not yet been fully reviewed. The main aim of this review is to summarize the effects of nutraceuticals and herbal bioactive compounds on plasma adiponectin concentrations based on clinical studies. It can be concluded that medicinal plants, and herbal bioactive compounds, particularly curcumin, anthocyanins, resveratrol, soy, walnut, and dihydromyricetin can be used as adjunct or complementary therapeutic agents to increase plasma adiponectin, which could potentially prevent and treat NCDs.
© 2021. The Author(s), under exclusive license to Springer Nature Switzerland AG.

Entities:  

Keywords:  Adiponectin; Insulin resistance; Noncommunicable diseases; Obesity; Phytochemicals

Mesh:

Substances:

Year:  2021        PMID: 34981470     DOI: 10.1007/978-3-030-73234-9_4

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  115 in total

1.  Cardiovascular health in childhood: A statement for health professionals from the Committee on Atherosclerosis, Hypertension, and Obesity in the Young (AHOY) of the Council on Cardiovascular Disease in the Young, American Heart Association.

Authors:  Christine L Williams; Laura L Hayman; Stephen R Daniels; Thomas N Robinson; Julia Steinberger; Stephen Paridon; Terry Bazzarre
Journal:  Circulation       Date:  2002-07-02       Impact factor: 29.690

2.  American Heart Association guidelines for primary prevention of atherosclerotic cardiovascular disease beginning in childhood.

Authors:  Rae-Ellen W Kavey; Stephen R Daniels; Ronald M Lauer; Dianne L Atkins; Laura L Hayman; Kathryn Taubert
Journal:  Circulation       Date:  2003-03-25       Impact factor: 29.690

Review 3.  Obesity-related non-communicable diseases: South Asians vs White Caucasians.

Authors:  A Misra; L Khurana
Journal:  Int J Obes (Lond)       Date:  2010-07-20       Impact factor: 5.095

4.  Adiponectin primes human monocytes into alternative anti-inflammatory M2 macrophages.

Authors:  Fina Lovren; Yi Pan; Adrian Quan; Paul E Szmitko; Krishna K Singh; Praphulla C Shukla; Milan Gupta; Lawrence Chan; Mohammed Al-Omran; Hwee Teoh; Subodh Verma
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-07-09       Impact factor: 4.733

Review 5.  Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome.

Authors:  Takashi Kadowaki; Toshimasa Yamauchi; Naoto Kubota; Kazuo Hara; Kohjiro Ueki; Kazuyuki Tobe
Journal:  J Clin Invest       Date:  2006-07       Impact factor: 14.808

Review 6.  The prevalence and trends of overweight, obesity and nutrition-related non-communicable diseases in the Arabian Gulf States.

Authors:  S W Ng; S Zaghloul; H I Ali; G Harrison; B M Popkin
Journal:  Obes Rev       Date:  2011-01       Impact factor: 9.213

7.  Adipocyte-derived plasma protein, adiponectin, suppresses lipid accumulation and class A scavenger receptor expression in human monocyte-derived macrophages.

Authors:  N Ouchi; S Kihara; Y Arita; M Nishida; A Matsuyama; Y Okamoto; M Ishigami; H Kuriyama; K Kishida; H Nishizawa; K Hotta; M Muraguchi; Y Ohmoto; S Yamashita; T Funahashi; Y Matsuzawa
Journal:  Circulation       Date:  2001-02-27       Impact factor: 29.690

Review 8.  Adiponectin, the past two decades.

Authors:  Zhao V Wang; Philipp E Scherer
Journal:  J Mol Cell Biol       Date:  2016-03-18       Impact factor: 6.216

9.  The adiponectin receptors AdipoR1 and AdipoR2 activate ERK1/2 through a Src/Ras-dependent pathway and stimulate cell growth.

Authors:  Mi-Hye Lee; Richard L Klein; Hesham M El-Shewy; Deirdre K Luttrell; Louis M Luttrell
Journal:  Biochemistry       Date:  2008-10-09       Impact factor: 3.162

10.  The burden of non communicable diseases in developing countries.

Authors:  Abdesslam Boutayeb; Saber Boutayeb
Journal:  Int J Equity Health       Date:  2005-01-14
View more
  1 in total

Review 1.  The Potential Role of Nutrition in Lung Cancer Establishment and Progression.

Authors:  Chiara Porro; Maria Ester La Torre; Nicola Tartaglia; Tarek Benameur; Mario Santini; Antonio Ambrosi; Giovanni Messina; Giuseppe Cibelli; Alfonso Fiorelli; Rita Polito; Gaetana Messina
Journal:  Life (Basel)       Date:  2022-02-12
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.